Antimicrobial peptides versus invasive infections

Current Topics in Microbiology and Immunology

Volumn 306, Issue , 2006, Pages 111-152

  Yeaman, M R ^a   Bayer, A S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; BETA DEFENSIN; BETA THROMBOGLOBULIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CELL PROTEIN; FIBRINOPEPTIDE A; FIBRINOPEPTIDE B; KINOCIDIN; LYSINE; PLATELET MICROBICIDAL PROTEIN; POLYPEPTIDE ANTIBIOTIC AGENT; RANTES; THROMBOCYTE BASIC PROTEIN; THROMBOCYTE FACTOR 4; THYMOSIN BETA4; UNCLASSIFIED DRUG; ANTIMICROBIAL CATIONIC PEPTIDE; PLASMA PROTEIN; PLATELET MICROBICIDAL PROTEIN, ORYCTOLAGUS CUNICULUS;

ANTIMICROBIAL ACTIVITY; BIOACCUMULATION; BLOOD FLOW; BLOOD VESSEL; CELLULAR IMMUNITY; EFFECTOR CELL; GASTROINTESTINAL MUCOSA; GENETIC LINE; GINGIVA; HOST RESISTANCE; HUMAN; INFECTION; INNATE IMMUNITY; LEUKOCYTE; MUCOSA; NONHUMAN; NOSE MUCOSA; OROPHARYNX; PHYLOGENY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SALMONELLA TYPHIMURIUM; SKIN; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTOPENIA; ANIMAL; COMPARATIVE STUDY; IMMUNOLOGY; INTESTINE MUCOSA; MOUTH MUCOSA; PHYSIOLOGY;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BLOOD PLATELETS; BLOOD PROTEINS; HUMANS; IMMUNITY, NATURAL; INFECTION; INTESTINAL MUCOSA; MOUTH MUCOSA; NASAL MUCOSA; SKIN;

EID: 33748098214     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/3-540-29916-5_5     Document Type: Review

References (112)

1. Bates DM, von Eiff C, McNamara PJ, Peters G, Yeaman MR, Bayer AS, Proctor RA (2003) Staphylococcus aureusmutants are as infective as the parent strains but the menadione biosyntheticmutant persists within the kidney. J Infect Dis 187:1654-1661
2. Bayer AS, Sullam PM, Ramos M, Li C, Cheung AL, Yeaman MR (1995) Staphylococus aureus induces platelet aggregation via a fibrinogen-dependent mechanismwhich is independent of principal platelet GPIIb/IIIa fibrinogen-binding domains. Infect Immun 63:3634-3641
3. Bayer AS, Ramos MD, Menzies BE, Yeaman MR, Shen AJ, Cheung AL (1997) Hyperproduction of α-toxin by Staphylococcus aureus results in paradoxically-reduced virulence in experimental endocarditis: a host defense role for platelet microbicidal proteins. Infect Immun 65:4652-4660
4. Bensing BA, Rubens CE, Sullam PM (2001) Genetic loci of Streptococcus mitis that mediate binding to human platelets. Infect Immun 69:1373-1380
5. Chang FY, Singh N, Gayowski T, Wagener MM, Mietzner SM, Stout JE, Marino IR (2000) Thrombocytopenia in liver transplant recipients: predictors, impact on fungal infections, and role of endogenous thrombopoietin. Transplantation 69:70-75
6. Cheung AL, Fischetti VA (1990) The role of fibrinogen in staphylococcal adherence to catheters in vitro. J Infect Dis 161:1177-1186
7. Christin L, Wyson DR, Meshulam T, Hastey R, Simons ER, Diamond RD (1996) Mechanisms and target sites of damage in killing of Candida albicans hyphae by human polymorphonuclear neutrophils. J Infect Dis 176:1567-1578
8. Clawson CC, White JG (1971) Platelet interaction with bacteria. II. Fate of bacteria. Am J Pathol 65:381-398
9. Cocchi F, DeVico AL, G-Demo A, Arya SK, Gallo RC, Lusso P (1995) Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 270:1811-1815
10. Cole AM, Dewan P, Ganz T (1999) Innate antimicrobial activity of nasal secretions. Infect Immun 67:3267-3275
11. Dankert J, Krijgsveld J, van Der Werff J, Joldersma W, Zaat SA (2001) Platelet microbicidal activity is an important defense factor against viridans streptococcal endocarditis. J Infect Dis 184:597-605
12. Darveau RP, Blake J, Seachord CL, Cosand WL, Cunninigham MD, Cassiano-Cough L, Maloney G (1992) Peptide related to the carboxy-terminus of human platelet factor IV with antibacterial activity. J Clin Invest 90:447-455
13. Dhawan VK, Bayer, AS, Yeaman MR (1998) In vitro resistance to thrombin-induced platelet microbicidal protein is associated with enhanced progression and hematogenous dissemination in experimental Staphylococcus aureus infective endocarditis. Infect Immun 66:3476-3479
14. Dhawan VK, Yeaman MR, Bayer AS (1999) Influence of in vitro susceptibility phenotype against thrombin-induced platelet microbicidal protein on treatment and prophylaxis outcomes of experimental Staphylococcus aureus endocarditis. J Infect Dis 180:1561-1568
15. Dhawan VK, Bayer AS, Yeaman MR (2000) Thrombin-induced platelet microbicidal protein susceptibility phenotype influences the outcome of oxacillin prophylaxis and therapy of experimental Staphylococcus aureus endocarditis. Antimicrob Agents Chemother 44:3206-3209
16. Deuel TF, Senior RM, Chang D, Griffith GL, Heinrikson RL, Kaiser ET (1981) Platelet factor-4 is chemotactic for neutrophils and monocytes. Proc Natl Acad Sci U S A 78:4548-4587
17. Essien EM, Ebhota MI (1983) Platelet secretory activities in acute malaria (Plasmodium falciparum) infection. Acta Haematol 70:183-188
18. Feldman C, Kallenbach JM, Levy H, Thorburn JR, Hurwitz MD, Koornhof HJ (1991) Comparison of bacteraemic community-acquired lobar pneumonia due to Streptococcus pneumoniae and Klebsiella pneumoniae in an intensive care unit. Respiration 58:265-270
19. Fields PL, Groisman EA, Heffron F (1989) A Salmonella locus that controls resistance to microbicidal proteins from phagocytic cells. Science 243:1059-1062
20. Filler SG, Joshi M, Phan QT, Diamond RD, Edwards JE Jr, Yeaman MR (1999) Platelets protect vascular endothelial cells from injury due to Candida albicans. Abstract 2163, 39th ICAAC, American Society for Microbiology. San Francisco, CA
21. Fodor J (1887) Die fahigkeit des blutes bakterien zu vernichten. Deutsch Med Wochenschr 13:745-747
22. Fowler VG, McIntyre LM, Yeaman MR, Peterson GE, Reller LB, Corey GR, Wray D, Bayer AS (2000) In vitro resistance to thrombin-induced platelet microbicidal protein in isolates of Staphylococcus aureus from endocarditis patients correlates with an intravascular device source. J Infect Dis 182:1251-1254
23. Fowler VG, Scheld WM, Bayer AS (2004) Endocarditis and intravascular infections. In: Mandell GL, Bennet JE, Dolin R (eds), Principles and practice of infectious diseases (6th edn.) Chap. 74. Churchill Livingstone, New York
24. Fowler VG Jr, Sakoulas G, McIntyre LM, Meka V, Arbeit RD, Cabell CH, Stryjewski ME, Eliopoulos GM, Reller LB, Corey GR, Jones T, Lucindo N, Yeaman MR, Bayer AS (2004) Persistent bacteremia due to MRSA infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein. J Infect Dis 190:1140-1149
25. Frohm M, Gunne H, Bergman AC, Agerberth B, Bergman T, Boman A, Lidén S, Jörnvall H, Boman HG (1996) Biochemical and antibacterial analysis of human wound and blister fluid. Eur J Biochem 237:86-92
26. Ganz T (2003) Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102:783-788
27. Ganz T, Metcalf JA, Gallin JI, Boxer LA, Lehrer RI (1988) Microbicidal/cytotoxic proteins of neutrophils are deficient in two disorders: Chediak-Higashi syndrome and "specific" granule deficiency. J Clin Invest 82:552-556
28. Ginsburg I (1988) The biochemistry of bacteriolysis: facts, paradoxes, and myths. Microbiol Sci 5:137-142
29. Harada K, Ohba K, Ozaki S, Isse K, Hirayama T, Wada A, Nakanuma Y (2004) Peptide antibiotic human beta-defensin-1 and -2 contribute to antimicrobial defense of the intrahepatic biliary tree. Hepatology 40:925-932
30. Herzberg MC, Gong K, MacFarlane GD, Erickson PR, Soberay AH, Krebsbach PH, Gopalraj M, Schilling K, Bowen WH (1990) Phenotypic characterization of Streptococcus sanguis virulence factors associated with bacterial endocarditis. Infect Immun 58:515-522
31. Isomoto H, Mukae H, Ishimoto H, Date Y, Nishi Y, Inoue K, Wada A, Hirayama T, Nakazato M, Kohno S (2004) Elevated concentrations of alpha-defensins in gastric juice of patients with Helicobacter pylori infection. Am J Gastroenterol 99:1916-1923
32. Johnson FB, Donaldson DM (1968) Purification of staphylocidal α-lysin from rabbit serum. J Bacteriol 96:589-595
33. Kirkpatrick B, Reeves DS, MacGowan AP (1994) A review of the clinical presentation, laboratory features, antimicrobial therapy and outcome of 77 episodes of pneumococcal meningitis occurring in children and adults. J Infect 29:171-182
34. Klinger MHF, Jelkmann W (2002) Role of blood platelets in infection and inflammation. J Interferon Cytokine Res 22:913-922
35. Koo SP, Bayer AS, Kagan BL, Yeaman MR (1999) Membrane permeabilization by thrombin-induced PMP-1 is modulated by transmembrane voltage polarity and magnitude. Infect Immun 67:2475-2481
36. Korzweniowski OM, Scheld WM, Bithell TC, Croft BH, Sande MA (1979) The effect of aspirin on the production of experimental Staphylococcus aureus endocarditis 19th ICAAC, American Society for Microbiology, Washington, DC
37. Krijgsveld J, Zaat SA, Meeldijk J, van Veelen P, Fang G, Poolman B, Brandt E, Ehlert J, Kuijpers A, Engbers G, Feijen J, Dankert J (2000) Thrombocidins, microbicidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines. J Biol Chem 275:20374-20381
38. Kristian SA, Durr M, Van Strijp JA, Neumeister B, Peschel A (2003) MprF-mediated lysinylation of phospholipids in Staphylococcus aureus leads to protection against oxygen-independent neutrophil killing. Infect Immun 71:546-549
39. Kupferwasser LI, Yeaman MR, Shapiro SM, Nast CC, Sullam PM, Filler SG, Bayer AS (1999) Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial dissemination, and frequency of embolic events in experimental Staphylococcus aureus endocarditis through antiplatelet and antibacterial effects. Circulation 99:2791-2797
40. Kupferwasser LI, Yeaman MR, Shapiro SM, Nast CC, Bayer AS (2002) In vitro susceptibility to thrombin-induced platelet microbicidal protein is associated with reduced disease progression and complication rates in experimental Staphylococcus aureus endocarditis: microbiological, histopathologic, and echocardiographic analyses. Circulation 105:746-752
41. Lau YE, Rozek A, Scott MG, Goosney DL, Davidson DJ, Hancock RE (2005) Interaction and cellular localization of the human host defense peptide LL-37 with lung epithelial cells. Infect Immun 73:583-591
42. Lehrer RI, Ganz T, Selsted ME (1988) Oxygen-independent bactericidal systems - mechanisms and disorders. Hematol Oncol Clin North Am 2:159-169
43. Lorenz R, Brauer M (1988) Platelet factor 4 (PF-4) in septicaemia. Infection 16:273-276
44. Mandell GL, Hook EW (1969) The interaction of platelets, Salmonella, and mouse peritoneal macrophages. Proc Soc Exp Biol Med 132:757-759
45. Mavrommatis AC, Theodoridis T, Orfanidou A, Roussos C, Christopoulou-Kokkinou V, Zakynthinos S (2000) Coagulation system and platelets are fully activated in uncomplicated sepsis. Crit. Care Med 28:451-457
46. Mayo KH, Chen MJ (1989) Human platelet factor 4monomer-dimer-tetramer equilibria investigated by 1H NMR spectroscopy. Biochemistry 28:9469-9478
47. Mercier RC, Rybak MJ, Bayer AS, Yeaman MR (2000) Influence of platelets and platelet microbicidal protein susceptibility on the fate of Staphylococcus aureus in an in vitro model of infective endocarditis. Infect Immun 68:4699-4705
48. Mercier RC, Dietz RM, Mazzola JL, Bayer AS, Yeaman MR (2004) Beneficial influence of platelets on antibiotic efficacy in an in vitro model of Staphylococcus aureus endocarditis. Antimicrob Agents Chemother 48:2551-2557
49. Meyer MW, Gong K, Herzberg MC (1998) Streptococcus sanguis-induced platelet clotting in rabbits and hemodynamic and cardiopulmonary consequences. Infect Immun 66:5906-5914
50. Mezzano S, Burgos ME, Ardiles L, Olavarria F, Concha M, Caorsi I, Aranda E, Mezzano D (1992) Glomerular localization of platelet factor 4 in streptococcal nephritis. Nephro 61:58-63
51. Myrvik QN (1956) Serum bactericidins active against Gram-positive bacteria. Ann N Y Acad Sci 66:391-400
52. Nachum R, Watson SW, Sullivan JD Jr, Seigel SE (1980) Antimicrobial defense mechanisms in the horseshoe crab, Limulus polyphemus: preliminary observations with heat-derived extracts of Limulus amoebocyte lysate. J Invert Pathol 32:51-58
53. Nicolau DP, Freeman CD, Nightingale CH, Quintiliani R, Coe CJ, Maderazo EG, Cooper, BW (1993) Reduction of bacterial titers by low-dose aspirin in experimental aortic valve endocarditis. Infect Immun 61:1593-1595
54. Nicolau DP, Marangos MN, Nightingale CH, Quintiliani R (1995) Influence of aspirin on development and treatment of experimental Staphylococcus aureus endocarditis. Antimicrob Agents Chemother 39:1748-1751
55. Nizet V, Ohtake T, Lauth X, Trowbridge J, Rudisill J, Dorschner RA, Pestonjamasp V, Piraino J, Huttner K, Gallo RL (2001) Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414:454-457
56. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL, Leung DY (2002) Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347:1151-1160
57. Oppenheim JJ, Yang D (2005) Alarmins: chemotactic activators of immune responses. Curr Opin Immunol 17:359-365
58. Osler W (1886) On certain problems in the physiology of the blood corpuscles. Med News 48:365-425
59. Park CH, Valore EV, Waring AJ, Ganz T (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276:7806-7810
60. Paulsen F, Pufe T, Conradi L, Varoga D, Tsokos M, Papendieck J, Petersen W. (2002a) Antimicrobial peptides are expressed and produced in healthy and inflamed human synovial membranes. J Pathol 198:369-377
61. Paulsen FP, Pufe T, Schaudig U, Held-Feindt J, Lehmann J, Thale AB, Tillmann BN (2002b) Protection of human efferent tear ducts by antimicrobial peptides. Adv Exp Med Biol 506:547-553
62. Putsep K, Carlsson G, Boman HG, Andersson M (2002) Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 360:1144-1149
63. Qiu B, Frait KA, Reich F, Komuniecki E, Chensue SW (2001) Chemokine expression dynamics in mycobacterial (type-1) and schistosomal (type-2) antigen-elicited pulmonary granuloma formation. Am J Pathol 158:1503-1515
64. Rucinski B, Niewiarowski S, Strzyzewski M, Holt JC, Mayo KH (1990) Human platelet factor 4 and its C-terminal peptides: heparin binding and clearance from the circulation. Thromb Haemost 63:493-498
65. Sakoulas G, Eliopoulos GM, Fowler VG, Moellering RC, Novick RP, Lucindo N, Yeaman MR, Bayer AS (2005) Staphylococcus aureus accessory gene regulator (agr) dysfunction and vancomycin exposure are associated with autolysin defect, glycopeptide intermediate susceptibility (GISA), and reduced antimicrobial peptide susceptibility phenotypes in vitro. Antimicrob Agents Chemother 49:2687-2692
66. Salzman NH, Ghosh D, Huttner KM, Paterson Y, Bevins CL (2003) Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 422:522-526
67. Santolaya ME, Alvarez AM, Aviles CL, Becker A, Cofre J, Enriquez N, O'Ryan M, Paya E, Salgado C, Silva P, Tordecilla J, Varas M, Villarroel M, Viviani T, Zubieta M (2002) Prospective evaluation of amodel of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia. Clin Infect Dis 35:678-683
68. Shafer WM, Martin LE, Spitznagel JK (1986) Late intraphagosomal hydrogen ion concentration favors the in vitro antimicrobial capacity of a 37-kilodalton cationic granule protein of human neutrophil granulocytes. Infect Immun 53:651-655
69. Shahan TA, Sorenson WG, Paulauskis JD, Morey R, Lewis DM (1998) Concentration and time-dependent upregulation and release of the cytokines MIP-2, KC, TNF, and MIP-1-α in rat alveolar macrophages by fungal spores implicated in airway inflammation. Am J Respir Cell Mol Biol 18:435-440
70. Shin JS, Kim CW, Kwon YS, Kim JC (2004) Human beta-defensin 2 is induced by interleukin-1beta in the corneal epithelial cells. Exp Mol Med 36:204-210
71. Shirafuji Y, Tanabe H, Satchell DP, Henschen-Edman A, Wilson CL, Ouellette AJ (2003) Structural determinants of procryptdin recognition and cleavage bymatrix metalloproteinase-7. J Biol Chem 278:7910-7919
72. Siboo IR, Cheung AL, Bayer AS, Sullam PM (2001) Clumping factor A mediates binding of Staphylococcus aureus to human platelets. Infect Immun 69:3120-3127
73. Sieprawska-Lupa M, Mydel P, Krawczyk K, Wojcik K, Puklo M, Lupa B, Suder P, Silberring J, Reed M, Pohl J, Shafer W, McAleese F, Foster T, Travis J, Potempa J (2004) Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother 48:4673-4679
74. Spitznagel JK (1984) Non-oxidative antimicrobial reactions of leukocytes. Contemp Top Immunobiol 14:283-343
75. Srichaikul T, Nimmannitya S, Sripaisarn T, Kamolsilpa M, Pulgate C (1989) Platelet function during the acute phase of dengue hemorrhagic fever. Southeast Asian J Trop Med Pub Health 20:19-25
76. Sullam PM, Frank U, Yeaman MR, Tauber MG, Bayer AS, Chambers HF (1993) Effect of thrombocytopenia on the early course of streptococcal endocarditis. J Infect Dis 168:910-914
77. Tang YQ, Yeaman MR, Selsted ME (2002) Antimicrobial peptides from human platelets. Infect Immun 70:6524-6533
78. Tew JG, Roberts RR, Donaldson DM (1974) Release of α-lysin fromplatelets by thrombin and by a factor produced in heparinized blood. Infect Immun 9:179-186
79. Tocantins LM (1938) The mammalian blood platelet in health and disease. Medicine 17:155-257
80. Trier DA, Bayer AS, Yeaman MR (2000) Staphylococcus aureus elicits antimicrobial responses from platelets via an ADP-dependent pathway. Abstract 1010, 40th ICAAC, American Society for Microbiology. Toronto, Canada
81. Turner RB, Liu L, Sazonova IY, Reed GL (2002) Structural elements that govern the substrate specificity of the clot-dissolving enzyme plasmin. J Biol Chem 277:33068-33074
82. Varoga D, Pufe T, Harder J, Meyer-Hoffert U, Mentlein R, Schroder JM, Petersen WJ, Tillmann BN, Proksch E, Goldring MB, Paulsen FP (2004) Production of endogenous antibiotics in articular cartilage. Arth Rheum 50:3526-3534
83. Viscoli C, Bruzzi P, Castagnola E, Boni L, Calandra T, Gaya H, Meuneir F, Feld R, Zinner S, Klastersky J et al (1994) Factors associated with bacteraemia in febrile, granulocytopenic patients. The International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Eur J Cancer 30:430-437
84. Walz A, Dewald B, vonTscharner V, Baggiolini M (1989) Effects of neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III, and platelet factor 4 on human neutrophils. J Exp Med 170:1745-1750
85. Weksler BB (1992) Platelets. In: Gallin J, Goldstein I, Snyderman R (eds) Inflammation: basic principles and clinical correlates, 2nd edn. Raven, New York, pp
86. Wilson M, Blum R, Dandona P, Mousa S (2001) Effects in humans of intravenously administered endotoxin on soluble cell-adhesion molecule and inflammatory markers: a model of human diseases. Clin Exp Pharmacol Physiol 28:376-380
87. Wu T, Yeaman MR, Bayer AS (1994) In vitro resistance to platelet microbicidal protein correlates with endocarditis source among staphylococcal isolates. Antimicrob Agents Chemother 38:729-732
88. Weidenmaier C, Peschel A, Xiong YQ, Kristian SA, Dietz K, Yeaman MR, Bayer AS (2005) Lack of wall teichoic acids in Staphylococcus aureus leads to reduced interactions with endothelial cells and to attenuated virulence in a rabbit model of endocarditis. J Infect Dis 191:1771-1777
89. Xiong YQ, Yeaman MR, Bayer AS (1999) In vitro antibacterial activities of platelet microbicidal protein and neutrophil defensin against Staphylococcus aureus are influenced by antibiotics differing in mechanism of action. Antimicrob Agents Chemother 43:1111-1117
90. Xiong YQ, Bayer AS, Yeaman MR (2002) Inhibition of Staphylococcus aureus intracellular macromolecular synthesis by thrombin-induced platelet microbicidal proteins. J Infect Dis 185:348-356
91. Xiong YQ, Bayer AS, Yeaman MR, van Wamel W, Cheung AL (2004) Impact of sarA and agr in Staphylococcus aureus upon fibronectin-binding protein A gene expression and fibronectin adherence capacity in vitro and in experimental infective endocarditis. Infect Immun 72:1832-1836
92. Xiong YQ, Mukhopadhyay K, Yeaman MR, Adler-Moore J, Bayer AS (2005) Functional interrelationships between cell membrane and wall in antimicrobial peptide-mediated killing of Staphylococcus aureus. Antimicrob Agents Chemother 49:3114-3121
93. Yamamoto Y, Klein TW, Friedman H (1997) Involvement of mannose receptor in cytokine interleukin-1beta (IL-1beta), IL-6, and granulocyte-macrophage colony-stimulating factor responses, but not in chemokine macrophage inflammatory protein 1beta (MIP-1beta), MIP-2, and KC responses, caused by attachment of Candida albicans to macrophages. Infect Immun 65:1077-1082
94. Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, Anderson M, Schroder JM, Wang JM, Howard OM, Oppenheim JJ (1999) Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286:525-528
95. Yang D, Chen Q, Hoover DM, Staley P, Tucker KD, Lubkowski J, Oppenheim JJ (2003) Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J Leukoc Biol 74:448-455
96. Yeaman MR (1997) The role of platelets in antimicrobial host defense. Clin Infect Dis 25:951-970
97. Yeaman MR (2004) Antimicrobial peptides fromplatelets in defense against cardiovascular infections. In: Devine DA, Hancock REW (eds.) Mammalian host defense peptides. Adv Mol Cell Micro. Cambridge University Press, Cambridge, pp 279-322
98. Yeaman MR, Bayer AS (1999) Antimicrobial peptides from platelets. Drug Resist. Updates 2:116-26
99. Yeaman MR, Bayer AS (2000) Staphylococcus aureus, platelets, and the heart. Curr Infect Dis Rep 2:281-298
100. Yeaman MR, Yount NY (2003) Mechanisms of antimicrobial peptide action and resistance. Pharm Rev 54:27-55
101. Yeaman MR, Yount NY (2005) Code among chaos: immunorelativity and the AEGIS model of antimicrobial peptides. ASM News 71:21-27
102. Yeaman MR, Norman DC, Bayer AS (1992) Platelet microbicidal protein enhances antibiotic-induced killing of and post-antibiotic effect in Staphylococcus aureus. Antimicrob Agents Chemother 36:1665-1670
103. Yeaman MR, Ibrahim A, Filler SG, Bayer AS, Edwards JE Jr, Ghannoum MA (1993) Thrombin-induced rabbit platelet microbicidal protein is fungicidal in vitro. Antimicrob Agents Chemother 37:546-553
104. Yeaman MR, Sullam PM, Dazin PF, Ghannoum MA, Edwards JE Jr, Bayer AS (1994a) Fluconazole and platelet microbicidal protein inhibit Candida adherence to platelets in vitro. Antimicrob Agents Chemother 38:1460-1465
105. Yeaman MR, Sullam PM, Dazin PF, Bayer AS (1994b) Platelet microbicidal protein alone and in combination with antibiotics reduces Staphylococcus aureus adherence to platelets in vitro. Infect Immun 62:3416-3423
106. Yeaman MR, Soldan SS, Ghannoum MA, Edwards JE Jr, Filler SG, Bayer AS (1996) Resistance to platelet microbicidal protein results in increased severity of experimental Candida albicans endocarditis. Infect Immun 64:1379-1384
107. Yeaman MR, Tang Y-Q, Shen AJ, Bayer AS, Selsted ME (1997) Purification and in vitro activities of rabbit platelet microbicidal proteins. Infect Immun 65:1023-1031
108. Yeaman MR, Bayer AS, Koo SP, Foss W, Sullam PM (1998) Platelet microbicidal proteins and neutrophil defensin disrupt the Staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action. J Clin Invest 101:178-187
109. Yeaman MR, Gank KD, Bayer AS, Brass EP (2002) Synthetic peptides that exert antimicrobial activities in whole blood and blood-derived matrices. Antimicro Agents Chemother 46:3883-3891
110. Yount NY, Gank KD, Xiong YQ, Bayer AS, Pender T, Welch WH, Yeaman MR (2004) Platelet microbicidal protein-1: structural themes of amultifunctional antimicrobial peptide. Antimicrob Agents Chemother 48:4395-4404
111. Zaiou M, Nizet V, Gallo RL (2003) Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence. J Invest Dermatol 120:810-816
112. Zanetti M (2004) Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol 75:39-48